|
复发性阔韧带骨外尤文氏肉瘤1例报道并文献复习
|
Abstract:
目的:探讨复发性骨外尤文氏肉瘤(EES)的疾病特征,了解其临床表现、诊断及治疗方案。方法:对1例阔韧带复发的EES患者的临床资料进行回顾性分析,复习相关文献并进行讨论。结果:该例EES患者临床表现及影像学特征缺乏特异性,确诊依赖于病理,其中免疫组化结果为CD99 (+),基因检测EWSR1基因易位,复发性EES治疗采用综合治疗,现术后放化疗中,一般状况好。结论:阔韧带EES极其罕见,具有易复发、易转移的特点,宜采取多模式联合的治疗策略,但复发和转移性尤因肉瘤的治疗仍是巨大挑战。
Objective: To investigate the disease characteristics of recurrent extraskeletal Ewing’s sarcoma (EES), and to understand its clinical manifestations, diagnosis and treatment. Methods: The clinical data of one EES patient with parametrial recurrence were retrospectively analyzed, and relevant literatures were reviewed and discussed. Results: The clinical manifestations and imaging features of this EES patient lacked specificity, and the diagnosis depended on pathology. The immunohisto-chemical results were CD99 (+), and the gene detection of EWSR1 gene translocation was performed. The recurrent EES was treated with comprehensive treatment. During chemotherapy, the general condition is good. Conclusion: Parametrial EES is extremely rare, and has the characteristics of easy recurrence and metastasis. A multimodal combined treatment strategy should be adopted, but the treatment of recurrent and metastatic Ewing sarcoma is still a huge challenge.
[1] | Grünewald, T.G.P., Cidre-Aranaz, F., Surdez, D., et al. (2018) Ewing Sarcoma. Nature Reviews Disease Primers, 4, 5.
https://doi.org/10.1038/s41572-018-0003-x |
[2] | 张雪梅, 郑莹, 姚先莹, 等. 阴道壁原始神经外胚层肿瘤1例及文献复习[J]. 现代妇产科进展, 2007, 16(4): 317-319. |
[3] | Chiang, S., Snuderl, M., Kojiro-Sanada, S., 等. 19例女性生殖道原始神经外胚层肿瘤形态学、免疫表型和分子学研究[J]. 临床与实验病理学杂志, 2017, 33(11): 1281. |
[4] | Wasilewski-Masker, K., Liu, Q., Yasui, Y., et al. (2009) Late Recurrence in Pediatric Cancer: A Report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute, 101, 1709-1720.
https://doi.org/10.1093/jnci/djp417 |
[5] | Wright, A., Desai, M., Bolan, C.W., et al. (2022) Extraskeletal Ewing Sarcoma from Head to Toe: Multimodality Imaging Review. Radiographics, 42, 1145-1160. https://doi.org/10.1148/rg.210226 |
[6] | Stahl, M., Ranft, A., Paulussen, M., et al. (2011) Risk of Recurrence and Survival after Relapse in Patients with Ewing Sarcoma. Pediatric Blood & Cancer, 57, 549-553. https://doi.org/10.1002/pbc.23040 |
[7] | Heinemann, M., Ranft, A., Langer, T., et al. (2018) Recurrence of Ewing Sarcoma: Is Detection by Imaging Follow-Up Protocol Associated with Survival Advantage? Pediatric Blood & Cancer, 65, e27011.
https://doi.org/10.1002/pbc.27011 |
[8] | Aryal, A., Kumar, V.S., Shamim, S.A., et al. (2021) What Is the Compara-tive Ability of 18F-FDG PET/CT, 99mTc- MDP Skeletal Scintigraphy, and Whole-Body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Clinical Orthopaedics and Related Research, 479, 1768-1779.
https://doi.org/10.1097/CORR.0000000000001681 |
[9] | Abboud, A., Masrouha, K., Saliba, M., et al. (2021) Ex-traskeletal Ewing Sarcoma: Diagnosis, Management and Prognosis. Oncology Letters, 21, Article No. 354. https://doi.org/10.3892/ol.2021.12615 |
[10] | Riggi, N., Suvà, M.L. and Stamenkovic, I. (2021) Ewing’s Sarcoma. The New England Journal of Medicine, 384, 154-164. https://doi.org/10.1056/NEJMra2028910 |
[11] | 颜语, 沈丹华. 尤文及尤文样肉瘤分子遗传学研究进展[J]. 中华病理学杂志, 2020, 49(2): 203-206. |
[12] | ESMO/European Sarcoma Network Working Group (2014) Bone Sarcomas: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 25, iii113-iii123. https://doi.org/10.1093/annonc/mdu256 |
[13] | Sorensen, P.H., Lessnick, S.L., Lopez-Terrada, D., et al. (1994) A Second Ewing’s Sarcoma Translocation, t(21;22), Fuses the EWS Gene to Another ETS-Family Transcription Factor, ERG. Nature Genetics, 6, 146-151.
https://doi.org/10.1038/ng0294-146 |
[14] | Xu, J., Xie, L., Sun, X., et al. (2019) Management of Recurrent or Re-fractory Ewing Sarcoma: A Systematic Review of Phase II Clinical Trials in the Last 15 Years. Oncology Letters, 18, 348-358. https://doi.org/10.3892/ol.2016.4575 |
[15] | Casali, P.G., Bielack, S., Abecassis, N., et al. (2018) Bone Sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 29, iv79-iv95. |
[16] | Applebaum, M.A., Worch, J., Matthay, K.K., et al. (2011) Clinical Features and Out-comes in Patients with Extraskeletal Ewing Sarcoma. Cancer, 117, 3027-3032. https://doi.org/10.1002/cncr.25840 |
[17] | 韩秀鑫, 张超, 陶芳, 等. 尤文肉瘤的治疗研究进展[J]. 重庆医学, 2019, 48(7): 1191-1195. |
[18] | Strauss, S.J., Frezza, A.M., Abecassis, N., et al. (2021) Bone Sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 32, 1520-1536.
https://doi.org/10.1016/j.annonc.2021.08.1995 |
[19] | 林小龙, 吕海苓, 王静, 等. 颈部骨外尤文氏肉瘤1例报道并文献复习[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(4): 473-476. |
[20] | El Weshi, A., Allam, A., Ajarim, D., et al. (2010) Extraskeletal Ewing’s Sarcoma Family of Tumours in Adults: Analysis of 57 Patients from a Single Institution. Clinical Oncology, 22, 374-381.
https://doi.org/10.1016/j.clon.2010.02.010 |
[21] | Galyfos, G., Karantzikos, G.A., Kavouras, N., et al. (2016) Ex-traosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management. Indian Journal of Surgery, 78, 49-53. https://doi.org/10.1007/s12262-015-1399-0 |
[22] | Theisen, E.R., Pishas, K.I., Saund, R.S., et al. (2016) Therapeutic Opportunities in Ewing Sarcoma: EWS-FLI Inhibition via LSD1 Targeting. Oncotarget, 7, 17616-17630. https://doi.org/10.18632/oncotarget.7124 |